Vimarsana
Biggest News Aggregation in the World

Page 7 - Nasdaq Cccc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Cccc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cccc Today - Breaking & Trending Today

C4 Therapeutics (NASDAQ:CCCC) Given New $5.00 Price Target at Bank of America - Vimarsana News

C4 Therapeutics (NASDAQ:CCCC) Given New $5.00 Price Target at Bank of America

C4 Therapeutics (NASDAQ:CCCC – Get Rating) had its target price cut by Bank of America from $11.00 to $5.00 in a report issued on Tuesday morning, The Fly reports. They currently have a neutral rating on the stock. A number of other research firms have also weighed in on CCCC. Morgan Stanley dropped their price […]

Cathay General Bancorp (NASDAQ:CATY) Sees Significant Growth in Short Interest - Vimarsana News

Cathay General Bancorp (NASDAQ:CATY) Sees Significant Growth in Short Interest

C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) was the recipient of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 2,920,000 shares, a decrease of 10.2% from the February 28th total of 3,250,000 shares. Currently, 7.2% of the company’s stock are short sold. Based […]

Bank of America Trims C4 Therapeutics (NASDAQ:CCCC) Target Price to $5.00 - Vimarsana News

Bank of America Trims C4 Therapeutics (NASDAQ:CCCC) Target Price to $5.00

C4 Therapeutics (NASDAQ:CCCC – Get Rating) had its price objective lowered by Bank of America from $11.00 to $5.00 in a research report released on Tuesday morning, The Fly reports. Bank of America currently has a neutral rating on the stock. CCCC has been the subject of several other research reports. JPMorgan Chase & Co. […]

Source: wkrb13.com
C4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Acquired by SG Americas Securities LLC - Vimarsana News

C4 Therapeutics, Inc. (NASDAQ:CCCC) Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC lifted its stake in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Rating) by 24.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,458 shares of the company’s stock after acquiring an additional 7,785 shares during the quarter. SG […]

C4 Therapeutics (CCCC) – Research Analysts' Weekly Ratings Changes - Vimarsana News

C4 Therapeutics (CCCC) – Research Analysts' Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of C4 Therapeutics (NASDAQ: CCCC) in the last few weeks: 4/18/2022 – C4 Therapeutics had its price target lowered by analysts at UBS Group AG from $64.00 to $26.00. They now have a “buy” rating on the stock. 4/11/2022 – C4 Therapeutics had its […]